Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market atazanavir capsules in the strengths of 150 mg, 200 mg and 300 mg.
Mylan Pharms Generic Atazanavir; Cobicistat Receives Tentative Approval in US
The European Medicines Agency (EMA) announced Friday that its Committee for Medicinal Products for Human Use (CHMP) recommended six medicines and nine indication extensions for approval, including for the first oral add-on treatment for type 1 diabetes, and issued its opinion on the sartan safety issues.
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Limited, (NYSE and TASE:TEVA) today announced the exclusive launch of a generic version of Reyataz®1 (atazanavir) capsules in the U.S.
EVOTAZ® (atazanavir and cobicistat): Gilead Sciences, Inc. v.Mylan Pharmaceuticals Inc.
Mylan S.A.S. Gets EU Nod For Atazanavir
Pharmacare's Generic Atazanavir Receives Approval In US
European regulators have approved Bristol-Myers Squibb’s Evotaz pills in combination with other antiretroviral agents for the treatment of adult patients infected with HIV-1.n nnnRead more at: http://www.pharmatimes.com/Article/15-07-16/EU_approves_BMS_once-daily_HIV_combo_pill.aspx#ixzz3g7UfATjl nFollow us: @PharmaTimes on Twitter
Government exempts AIDS drugs from customs duty
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.